Citadel Advisors’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.3M Buy
182,365
+168,165
+1,184% +$7.96M ﹤0.01% 3734
2025
Q4
$639K Sell
14,200
-3,794
-21% -$176K ﹤0.01% 8422
2025
Q3
$804K Buy
17,994
+11,494
+177% +$550K ﹤0.01% 8021
2025
Q2
$312K Buy
6,500
+1,736
+36% +$75.5K ﹤0.01% 9719
2025
Q1
$191K Buy
4,764
+4,570
+2,356% +$192K ﹤0.01% 10515
2024
Q4
$8.91K Sell
194
-37,820
-99% -$1.69M ﹤0.01% 13668
2024
Q3
$1.78M Sell
38,014
-27,878
-42% -$1.27M ﹤0.01% 5756
2024
Q2
$2.78M Sell
65,892
-22,273
-25% -$977K ﹤0.01% 4702
2024
Q1
$3.9M Buy
88,165
+75,151
+577% +$3.43M ﹤0.01% 4344
2023
Q4
$599K Sell
13,014
-47,059
-78% -$2M ﹤0.01% 7697
2023
Q3
$2.58M Buy
60,073
+45,550
+314% +$2.12M ﹤0.01% 4759
2023
Q2
$693K Buy
14,523
+5,564
+62% +$268K ﹤0.01% 7224
2023
Q1
$436K Sell
8,959
-43,758
-83% -$2.23M ﹤0.01% 8585
2022
Q4
$2.79M Sell
52,717
-54,320
-51% -$2.68M ﹤0.01% 4872
2022
Q3
$4.68M Buy
107,037
+34,799
+48% +$1.72M ﹤0.01% 3987
2022
Q2
$3.62M Sell
72,238
-2,924
-4% -$143K ﹤0.01% 4419
2022
Q1
$3.9M Sell
75,162
-44,606
-37% -$2.3M ﹤0.01% 4659
2021
Q4
$7.06M Buy
119,768
+19,427
+19% +$1.11M ﹤0.01% 3702
2021
Q3
$5.5M Buy
100,341
+35,459
+55% +$1.97M ﹤0.01% 4129
2021
Q2
$3.33M Buy
64,882
+9,902
+18% +$511K ﹤0.01% 5355
2021
Q1
$2.84M Buy
54,980
+14,146
+35% +$777K ﹤0.01% 5569
2020
Q4
$2.29M Sell
40,834
-15,561
-28% -$830K ﹤0.01% 5084
2020
Q3
$3.13M Buy
56,395
+18,390
+48% +$954K ﹤0.01% 3916
2020
Q2
$1.73M Sell
38,005
-49,416
-57% -$2.21M ﹤0.01% 4833
2020
Q1
$3.86M Sell
87,421
-108,829
-55% -$4.25M ﹤0.01% 3088
2019
Q4
$7.03M Buy
196,250
+155,793
+385% +$5.79M ﹤0.01% 2635
2019
Q3
$1.41M Buy
40,457
+10,656
+36% +$410K ﹤0.01% 5030
2019
Q2
$1.28M Buy
29,801
+17,353
+139% +$719K ﹤0.01% 5297
2019
Q1
$537K Sell
12,448
-4,716
-27% -$190K ﹤0.01% 6672
2018
Q4
$627K Buy
17,164
+755
+5% +$28K ﹤0.01% 6054
2018
Q3
$659K Buy
16,409
+9,242
+129% +$369K ﹤0.01% 6253
2018
Q2
$275K Buy
+7,167
New +$264K ﹤0.01% 7352
2017
Q3
Sell
-6,130
Closed -$218K 7933
2017
Q2
$218K Buy
+6,130
New +$207K ﹤0.01% 6430

Other funds holding QGEN

Citadel Advisors's QGEN Position: Q1 2026 in Review

Citadel Advisors increased its Qiagen (QGEN) stake by 23% in Q1 2026, buying an estimated $4.69M and bringing the position to 531,381 shares worth $21.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2264.

Citadel Advisors first reported a position in QGEN in Q1 2017 and has held it in 37 quarters since. The position peaked at $96.2M in Q3 2024. 344 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Citadel Advisors held 531,381 shares of Qiagen worth $21.3M as of Q1 2026.
  • Citadel Advisors bought 99,133 Qiagen shares in Q1 2026, an estimated $4.69M.
  • Qiagen made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2264 holding.
  • Citadel Advisors first reported a position in Qiagen in Q1 2017 and has held it in 37 quarters since.
  • Citadel Advisors's Qiagen position peaked at $96.2M in Q3 2024.
  • 344 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.